Neonatal Hypoglycemia: What Nonclinical Birth Workers Should Understand

By Birth & Baby University · Last updated: October 2026 · 8 min read

Low blood sugar in newborns is a topic where doulas hear strong statements from both directions. Some families are told their baby needs formula, a gel or a NICU stay because of a number on a meter. Others are told that blood sugar checks are overdone and that healthy newborns adjust on their own. Both statements contain truth, and neither is a reason for a doula to interpret glucose results. What a nonclinical birth worker needs is a clear understanding of what neonatal hypoglycemia is, why clinicians disagree about thresholds, which babies are monitored, what the common treatments are and how their evidence looks, and what to do and not do at home. This article draws on the Academy of Breastfeeding Medicine (ABM) protocol, the American Academy of Pediatrics (AAP) report and recent trials and reviews.

Key takeaways

Quick answer: a temporary fall in glucose is part of normal adaptation after birth in many babies, but profound, persistent or recurrent hypoglycemia can injure the brain. Clinicians monitor babies with specific risk factors, feed early, and treat according to local protocols. The AAP says current evidence does not support a single glucose concentration that separates normal from abnormal. Doulas should know the risk groups and warning signs, support early feeding and skin-to-skin contact, and never interpret or treat glucose results.

• The AAP report states that current evidence does not support a specific concentration of glucose that can discriminate normal from abnormal or can potentially result in acute or chronic irreversible neurologic damage, and recommends identifying at-risk infants early and using prophylactic measures as a pragmatic approach.
• The ABM protocol (revised 2021) lists risk groups for routine glucose monitoring, including infants of mothers with diabetes, small-for-gestational-age and large-for-gestational-age infants, late preterm infants, and babies with perinatal stress or cold stress, and says healthy term infants need no routine supplementation with water, glucose water or formula.
• A randomized dose-finding trial of 416 at-risk babies found the risk of hypoglycemia was lowest with a single 200 mg/kg dose of 40% dextrose gel (relative risk 0.68), but a 2026 meta-analysis of eight trials with 4,368 neonates found dextrose gel did not significantly reduce hypoglycemia, treatment failure, NICU admission or breastfeeding interruption overall.
• The ABM lists signs of possible hypoglycemia such as jitteriness, irritability, poor suck, lethargy, apnea and seizures, and notes that these signs are nonspecific.

What the research says

Why thresholds are contested. The AAP’s report on postnatal glucose homeostasis in late-preterm and term infants (Committee on Fetus and Newborn, Adamkin, 2011) offers a practical guide and algorithm for screening and management. It states that current evidence does not support a specific concentration of glucose that discriminates normal from abnormal or predicts irreversible neurologic damage, and recommends early identification of at-risk infants and prophylactic measures despite the absence of a consistent definition of hypoglycemia. The ABM’s Clinical Protocol #1 (revised 2021) describes the same tension. It notes that a transient low glucose is usually self-limited, asymptomatic and part of adaptation to postnatal life, but that profound, persistent or recurrent hypoglycemia, especially in a previously healthy term newborn with no risk factors, needs evaluation. It cites a trial of 689 at-risk newborns comparing treatment thresholds of 36 and 47 mg/dL and reports different operational thresholds in a table. It also records that overtreatment of asymptomatic transitional newborns carries costs, including parental anxiety, painful procedures, unnecessary formula, reduced breastfeeding and avoidable NICU admission, while undertreatment of persistent hypoglycemia carries its own danger. Individual hospitals follow their own protocols, so numbers vary.

Who is monitored and what to look for. The ABM protocol states that infants at increased risk should be routinely monitored for blood glucose irrespective of feeding mode, and lists risk groups in two broad categories: excess use of glucose (such as hyperinsulinemic states) and inadequate production or supply. Maternal conditions include pre-existing or gestational diabetes, pre-eclampsia or hypertension, and some medications. Neonatal conditions include growth restriction, low birth weight, small-for-gestational-age babies, large-for-gestational-age babies with macrosomic appearance, discordant twins, prematurity, perinatal stress, cold stress, polycythemia and certain syndromes. It adds that large-for-gestational-age babies born to screened non-diabetic mothers appear not to be at risk. Table 1 of the protocol lists signs that may reflect hypoglycemia: irritability, tremors and jitteriness, tachypnea, sweating, pallor, temperature instability, high-pitched cry, excessive hunger signs, vomiting, poor suck or feeding refusal, and in the more severe category lethargy, limpness, seizures, apnea and cyanosis. It cites a study in which only jitteriness and tachypnea were predictive of low blood glucose, and cautions that jitteriness is very nonspecific and will produce many false positives. The management section says all stable infants should start breastfeeding as soon as possible after birth, hopefully within 30 to 60 minutes, that at-risk infants should be offered breastfeeding during the 6 to 8 hour rest period that some infants have after the first awake period, that skin-to-skin contact helps maintain temperature and reduce energy expenditure, and that routine supplementation of healthy term infants with water, glucose water or formula is unnecessary.

Treatments: dextrose gel. Buccal 40% dextrose gel has been studied for prevention and treatment. In the Pre-hPOD dose-finding trial (Hegarty and colleagues, 2016), 416 babies at risk (infants of mothers with diabetes, late preterm, small or large birth weight) were randomized to one of four dextrose gel regimens or placebo. The risk of hypoglycemia (below 2.6 mM) in the first 48 hours was lowest with a single 200 mg/kg dose at one hour of age (relative risk 0.68, 95% confidence interval 0.47 to 0.99), though dose groups did not differ significantly, and single doses were better tolerated. The ABM protocol discusses randomized trials of the gel and a 2017 suggestion that it should be considered first-line treatment. A 2026 meta-analysis (Al-Enezi and colleagues) of eight randomized trials with 4,368 neonates, however, found that dextrose gel did not significantly reduce hypoglycemia, treatment success, recurrent hypoglycemia, NICU admission, breastfeeding at discharge or formula feeding, with a 24% reduction in NICU admission appearing only when one large trial was excluded. The authors conclude it is safe and low-cost but that current evidence does not support routine use as a standalone intervention, and they note heterogeneity across protocols. So the best-known gel trial found a benefit in a prevention setting and a later pooled analysis did not, which is exactly why local protocols differ and why a doula should never tell a family what their hospital should do.

What this means for doulas

• Know the risk groups. If a family says the baby is being monitored for low sugar, it is usually because of diabetes in pregnancy, size, prematurity or another risk factor, and they deserve calm reassurance that monitoring is a precaution.
• Support what the ABM and AAP both emphasize. Early feeding, skin-to-skin contact and keeping the baby warm. Never suggest water, sugar water or home remedies.
• Do not interpret numbers or treat. Thresholds, meters and treatment are clinicians’ decisions, and the sources disagree on numbers.
• Recognize red flags at home. Poor suck or feeding refusal, lethargy or limpness, jitteriness that does not settle with feeding, a high-pitched cry, breathing pauses or color change need prompt medical attention. Seizures, apnea or an unresponsive baby need emergency services. See Recognizing When a Newborn Needs Medical Evaluation: Essential Red Flags for Postpartum Doulas.
• Be careful with jitteriness. Newborns tremble in many normal situations, and the ABM calls the sign nonspecific. Report it, do not diagnose from it.

Putting the evidence into practice

1. Prenatally, ask about risk factors. Diabetes, hypertension, medications and growth concerns are worth mentioning to the pediatric team as the family understands them.
2. Support the first feed. Encourage skin-to-skin and early breastfeeding or the family’s chosen feeding plan, as in The First Hour After Birth: Why Early Feeding Support Matters.
3. Prepare for monitoring. Explain that heel sticks are common for at-risk babies and may be repeated, and that a family can ask the nurse what the plan is.
4. At home, track feeds, diapers and alertness. A baby who feeds poorly or is hard to wake needs same-day contact with the provider.
5. Refer. Any concern about feeding, tone, breathing or color goes to the pediatric provider.

Limits and uncertainty

There is no agreed glucose number that predicts harm, and guideline thresholds differ between organizations, as the AAP and ABM both acknowledge. The AAP report dates from 2011, and this article draws only on its abstract. This article draws on the ABM protocol in part, not in full. The dextrose gel evidence is mixed, and this article draws on abstracts of the trial and the meta-analysis. The Pediatric Endocrine Society’s guidance on persistent hypoglycemia is mentioned by the ABM but it was not read directly, and this article does not address persistent hypoglycemia beyond the first days. Practices at a given hospital depend on its own protocol, and babies in the NICU follow separate care.

The bottom line

Neonatal hypoglycemia can be a normal adjustment or a danger sign, and clinicians disagree about thresholds because the evidence does not draw a single line. At-risk babies are monitored, feeding and skin-to-skin contact are first-line support, and treatments such as dextrose gel have mixed trial evidence. A doula’s role is to know the risk groups and warning signs, support early feeding and warmth, avoid interpreting numbers or giving anything by mouth, and send concerns to the baby’s clinicians without delay.

Birth & Baby University’s For Doulas page sets out its birth doula training, postpartum doula training, recertification and mentorship for doulas who support families around birth and the newborn weeks. Confirm that any program meets your certifier’s, employer’s or state’s requirements before you enroll.

This article is for professional education. It is not medical, legal or tax advice. Check the standards of your certifying organization and the rules where you work. For concerns about a baby’s health, contact a pediatric provider or emergency services.

Sources and further reading

• Committee on Fetus and Newborn; Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics (2011). Read the source
• Wight NE; Academy of Breastfeeding Medicine. ABM Clinical Protocol #1: Guidelines for glucose monitoring and treatment of hypoglycemia in term and late preterm neonates, revised 2021. Breastfeeding Medicine (2021). Read the source
• Hegarty JE, et al. Prophylactic oral dextrose gel for newborn babies at risk of neonatal hypoglycaemia: a randomised controlled dose-finding trial (the Pre-hPOD Study). PLOS Medicine (2016). Read the source
• Al-Enezi RT, et al. Efficacy of oral dextrose gel for neonatal hypoglycaemia: an updated systematic review and meta-analysis of randomized controlled trials with 4368 patients. Endocrinology, Diabetes & Metabolism (2026). Read the source

More for professionals: the Professionals Blog.